December 1, 2021Open Access

Amyloid PET quantification using low-dose CT-guided anatomic standardization

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Low-dose CT of PET/CT can substitute for MRI in the anatomic standardization used to calculate the CL scale from amyloid PET, although a slight underestimation occurs.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Matsuda et al. (Wed,) studied this question.

synapsesocial.com/papers/69dbc6793d9adb00e768507c https://doi.org/https://doi.org/10.1186/s13550-021-00867-7

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Quantitative Evaluation of 18F-Flutemetamol PET in Patients With Cognitive Impairment and Suspected Alzheimer's Disease: A Multicenter Study2021 · 50 citations
2Clinical impact of [18F]flutemetamol PET among memory clinic patients with an unclear diagnosis2019 · 59 citations
3Unified segmentation2005 · 7,543 citations
4The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease2011 · 18,874 citations
5Assessing Amyloid Pathology in Cognitively Normal Subjects Using <sup>18</sup>F-Flutemetamol PET: Comparing Visual Reads and Quantitative Methods2018 · 75 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo